Clinical Trial Results:
A Phase 3, Open-Label Extension of COURAGE-ALS
(CY 5031)
Summary
|
|
EudraCT number |
2021-004727-33 |
Trial protocol |
IE BE NL SE FR IT ES PT DK |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
11 Sep 2024
|
First version publication date |
11 Sep 2024
|
Other versions |
|
Summary report(s) |
CY 5032 Clinical Trial Results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.